Discovery Lithium’s 2023 Exploration Program Sets the Stage for 2024
VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) — Discovery Lithium Inc. (CSE: DCLI) (OTC: DCLIF) (FRA: Q3Q0) (WKN: A3EFKA) […]
Comscore and TEGNA Sign Multi-Year Agreement for Local Linear and Cross-Platform Audience Measurement
RESTON, Va., March 01, 2024 (GLOBE NEWSWIRE) — Comscore, Inc. (NASDAQ: SCOR) and TEGNA Inc. (NYSE: TGNA) today announced they […]
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories
Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global rights to exarafenib and […]
Dyadic to Attend Industry Events in March
JUPITER, Fla. , March 01, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global […]
Immuneering Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
– Topline data from the Phase 1 portion of Phase 1/2a trial of IMM-1-104 expected in March 2024 – – […]
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
HIGH POINT, N.C., March 01, 2024 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused […]
Aemetis to Review Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
CUPERTINO, CA, March 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will […]
Fate Therapeutics to Present at Upcoming March Investor Conferences
SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage […]
BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024
Data from Phase 2a trial in Parkinson’s Disease suggest patients treated with NE3107 experienced significant improvements in non-motor symptoms and […]
Karat Packaging to Report 2023 Fourth Quarter and Full Year Financial Results and Host Conference Call on Thursday, March 14, 2024
CHINO, Calif., March 01, 2024 (GLOBE NEWSWIRE) — Karat Packaging Inc. (“Karat” or the “Company”) (Nasdaq: KRT), a specialty distributor […]
